Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 106

Neusoft Reach drives through $101m round

Neusoft’s automotive software unit, which is co-owned by Alpine Electronics, will use the money to enhance its products, develop new offerings and increase its market share.

Oct 15, 2021

Elliptic decrypts $60m series C round

SoftBank Vision Fund 2, Wells Fargo Strategic Capital and SBI Group were among the investors filling up the risk analysis software provider's coffers in its latest round.

Oct 15, 2021

Huakong TsingJiao checks off $78m series B

Lenovo Capital, Oppo and XunceTech were among the investors in the data protection software developer’s latest round, with the cash raised at a $621m valuation.

Oct 15, 2021

M2P Fintech hauls in $35m

DMI Group was among the investors in a series C round valuing the banking API developer at $355m post-money.

Oct 15, 2021

Atome attains $500m from Standard Chartered

SoftBank-backed fraud detection software provider AIG’s BNPL subsidiary has entered into a decade-long collaboration scheme with Standard Chartered alongside the deal.

Oct 14, 2021

Vision Fund 2 adorns Vuori with $400m

The SoftBank vehicle provided the cash at a $4bn valuation and it will support the outdoor apparel brand's domestic and international growth.

Oct 14, 2021

GPS navigates its way to $300m

Advent International and Viking Global Investors are set to take control of the Visa-backed payment processing technology provider once the transaction is completed.

Oct 14, 2021

Trumid traps $208m in funding

Singapore Exchange reinvested in the bond trading platform developer at a $2.4bn valuation, in a round led by Point Break Capital Management.

Oct 14, 2021

Hibob hits $150m in series C round

The Sumitomo and Seek-backed employee management software provider hiked its total funding to $274m in a round valuing it at $1.65bn.

Oct 14, 2021

CinCor Pharma bags $143m

Eli Lilly participated in a series B round for the cardiorenal treatment specialist that will support clinical drug trials, boosting its overall funding to $193m.

Oct 14, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here